October 30, 2019 from 4:00 PM - 7:00 PM
BioLabs@NYULangone
180 Varick St.
New York, NY 10014 (6th Floor)
Keynote Speaker
Mark Tomishima: Executive Director, Genome Engineering & Discovery Biology at BlueRock TherapeuticsHe is responsible for bioprocess improvement and characterization of neural cell types at BlueRock. He also oversees their efforts in genome engineering at the NYC R&D site. The lead product is a cell therapy that he hopes will combat Parkinson’s disease. He is actively developing a pipeline of neural cell products.